Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
Primary Purpose
Endometritis
Status
Withdrawn
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Azithromycin
Cefazolin
Sponsored by
About this trial
This is an interventional prevention trial for Endometritis
Eligibility Criteria
Inclusion Criteria:
- Pregnant patients between 37 and 42 weeks gestational weeks.
- Pregnant patients undergoing indicated cesarean section at Truman Medical Center Hospital July 2012 and July 2014.
- Pregnant patient that received prenatal care at Truman Medical Center. Hospital Hill, Samuel Rogers or Swope Parkway health centers at least 1 month prior to the Cesarean delivery.
- Signed informed consent.
Exclusion Criteria:
- Allergy to cephalosporins or azithromycin.
- Refusal to sign consent form.
- Clinical signs of chorioamnionitis: fever 100.4 F or higher, uterine tenderness, maternal or fetal tachycardia.
- Immunocompromised condition: HIV positive with CD4 count below 200, chronic steroid use, pregestational diabetes, cancer, chemotherapy.
- Need for emergent cesarean precluding consent or availability of study medication.
- Need for hysterectomy at cesarean section.
- Use of antibiotic in the 72 hours prior to admission.
Sites / Locations
- Truman Medical Center - Hospital Hill
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Cefazolin
Cefazolin + Azitrhromycin
Arm Description
single antibiotic
double antibiotic
Outcomes
Primary Outcome Measures
Development of post cesarean endometritis
Secondary Outcome Measures
Hospital stay length
Full Information
NCT ID
NCT01721616
First Posted
November 1, 2012
Last Updated
May 4, 2015
Sponsor
University of Missouri, Kansas City
1. Study Identification
Unique Protocol Identification Number
NCT01721616
Brief Title
Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
Official Title
A Randomized Clinical Trial of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Withdrawn
Why Stopped
Poor enrollment
Study Start Date
November 2012 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri, Kansas City
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Despite the generalized use of preoperative antibiotic prophylaxis, endometritis remains as the most frequent post-cesarean delivery complication. This increased morbidity translates into extended post-partum antibiotic use and prolongation of hospital stay with the subsequent increase in health care expenses. The current regimen recommended by the American College of Obstetricians and Gynecologists for cesarean delivery prophylaxis (1st generation cephalosporins) does not cover for Ureaplasma Urealyticum, a microorganism that has been associated with an increased risk of endometritis in post-cesarean section patients. Azithromycin, an antibiotic that has both aerobic and some anaerobic coverage, uniquely covers Ureaplasma and would be an excellent second antibiotic for cesarean section chemoprophylaxis. Our hypothesis is that the addition of azithromycin to standard chemoprophylaxis with cefazolin can effect a 25% reduction of post-cesarean section endometritis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometritis
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cefazolin
Arm Type
Active Comparator
Arm Description
single antibiotic
Arm Title
Cefazolin + Azitrhromycin
Arm Type
Active Comparator
Arm Description
double antibiotic
Intervention Type
Drug
Intervention Name(s)
Azithromycin
Intervention Type
Drug
Intervention Name(s)
Cefazolin
Primary Outcome Measure Information:
Title
Development of post cesarean endometritis
Time Frame
3-4 days while in hospital during post partum period
Secondary Outcome Measure Information:
Title
Hospital stay length
Time Frame
3-4 days while in hospital during post partum period
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Pregnant patients between 37 and 42 weeks gestational weeks.
Pregnant patients undergoing indicated cesarean section at Truman Medical Center Hospital July 2012 and July 2014.
Pregnant patient that received prenatal care at Truman Medical Center. Hospital Hill, Samuel Rogers or Swope Parkway health centers at least 1 month prior to the Cesarean delivery.
Signed informed consent.
Exclusion Criteria:
Allergy to cephalosporins or azithromycin.
Refusal to sign consent form.
Clinical signs of chorioamnionitis: fever 100.4 F or higher, uterine tenderness, maternal or fetal tachycardia.
Immunocompromised condition: HIV positive with CD4 count below 200, chronic steroid use, pregestational diabetes, cancer, chemotherapy.
Need for emergent cesarean precluding consent or availability of study medication.
Need for hysterectomy at cesarean section.
Use of antibiotic in the 72 hours prior to admission.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pedro Morales, MD
Organizational Affiliation
University of Missouri, Kansas City
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Katherine Goodpasture, DO
Organizational Affiliation
University of Missouri, Kansas City
Official's Role
Principal Investigator
Facility Information:
Facility Name
Truman Medical Center - Hospital Hill
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64108
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
We'll reach out to this number within 24 hrs